肺鳞状细胞癌肿瘤出芽的多中心研究:活检与切除的比较及观察者间变异性评估。

IF 7.1 1区 医学 Q1 PATHOLOGY
Marie Maillard , Christina Neppl , Philipp Zens , Julie Anex , Solange Peters , Thorsten Krueger , Sabina Berezowska
{"title":"肺鳞状细胞癌肿瘤出芽的多中心研究:活检与切除的比较及观察者间变异性评估。","authors":"Marie Maillard ,&nbsp;Christina Neppl ,&nbsp;Philipp Zens ,&nbsp;Julie Anex ,&nbsp;Solange Peters ,&nbsp;Thorsten Krueger ,&nbsp;Sabina Berezowska","doi":"10.1016/j.modpat.2024.100571","DOIUrl":null,"url":null,"abstract":"<div><p>Grading lung squamous cell carcinoma (LUSC) is controversial and not universally accepted. The histomorphologic feature of tumor budding (TB) is an established independent prognostic factor in colorectal cancer, and its importance is growing in other solid cancers, making it a candidate for inclusion in tumor grading schemes. We aimed to compare TB between preoperative biopsies and resection specimens in pulmonary squamous cell carcinoma and assess interobserver variability. A retrospective cohort of 249 consecutive patients primarily resected with LUSC in Bern (2000-2013, n = 136) and Lausanne (2005-2020, n = 113) with available preoperative biopsies was analyzed for TB and additional histomorphologic parameters, such as spread through airspaces and desmoplasia, by 2 expert pathologists (M.M., C.N.). Results were correlated with clinicopathologic parameters and survival. In resection specimens, peritumoral budding (PTB) score was low (0-4 buds/0.785 mm<sup>2</sup>) in 47.6%, intermediate (5-9 buds/0.785 mm<sup>2</sup>) in 27.4%, and high (≥10 buds/0.785 mm<sup>2</sup>) in 25% of cases (median bud count, 5; IQR, 0-26). Both the absolute number of buds and TB score were similar when comparing tumor edge and intratumoral zone (<em>P</em> = .192) but significantly different from the score obtained in the biopsy (<em>P</em> &lt; .001). Interobserver variability was moderate, regardless of score location (Cohen kappa, 0.59). The discrepant cases were reassessed, and consensus was reached in all cases with identification of causes of discordance. TB score was significantly associated with stage (<em>P</em> = .002), presence of lymph node (<em>P</em> = .033), and distant metastases (<em>P</em> = .020), without significant correlation with overall survival, tumor size, or pleural invasion. Desmoplasia was significantly associated with higher PTB (<em>P</em> &lt; .001). Spread through airspaces was present in 34% and associated with lower PTB (<em>P</em> &lt; .001). To conclude, despite confirming TB as a reproducible factor in LUSC, we disclose areas of scoring ambiguity. Preoperative biopsy evaluation was insufficient in establishing the final TB score of the resected tumor.</p></div>","PeriodicalId":18706,"journal":{"name":"Modern Pathology","volume":"37 10","pages":"Article 100571"},"PeriodicalIF":7.1000,"publicationDate":"2024-07-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0893395224001510/pdfft?md5=436d2a133269a6ef5b07a831d4ca6b68&pid=1-s2.0-S0893395224001510-main.pdf","citationCount":"0","resultStr":"{\"title\":\"Multicenter Study on Tumor Budding in Lung Squamous Cell Carcinoma: Comparison Between Biopsy and Resection With Interobserver Variability Assessment\",\"authors\":\"Marie Maillard ,&nbsp;Christina Neppl ,&nbsp;Philipp Zens ,&nbsp;Julie Anex ,&nbsp;Solange Peters ,&nbsp;Thorsten Krueger ,&nbsp;Sabina Berezowska\",\"doi\":\"10.1016/j.modpat.2024.100571\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>Grading lung squamous cell carcinoma (LUSC) is controversial and not universally accepted. The histomorphologic feature of tumor budding (TB) is an established independent prognostic factor in colorectal cancer, and its importance is growing in other solid cancers, making it a candidate for inclusion in tumor grading schemes. We aimed to compare TB between preoperative biopsies and resection specimens in pulmonary squamous cell carcinoma and assess interobserver variability. A retrospective cohort of 249 consecutive patients primarily resected with LUSC in Bern (2000-2013, n = 136) and Lausanne (2005-2020, n = 113) with available preoperative biopsies was analyzed for TB and additional histomorphologic parameters, such as spread through airspaces and desmoplasia, by 2 expert pathologists (M.M., C.N.). Results were correlated with clinicopathologic parameters and survival. In resection specimens, peritumoral budding (PTB) score was low (0-4 buds/0.785 mm<sup>2</sup>) in 47.6%, intermediate (5-9 buds/0.785 mm<sup>2</sup>) in 27.4%, and high (≥10 buds/0.785 mm<sup>2</sup>) in 25% of cases (median bud count, 5; IQR, 0-26). Both the absolute number of buds and TB score were similar when comparing tumor edge and intratumoral zone (<em>P</em> = .192) but significantly different from the score obtained in the biopsy (<em>P</em> &lt; .001). Interobserver variability was moderate, regardless of score location (Cohen kappa, 0.59). The discrepant cases were reassessed, and consensus was reached in all cases with identification of causes of discordance. TB score was significantly associated with stage (<em>P</em> = .002), presence of lymph node (<em>P</em> = .033), and distant metastases (<em>P</em> = .020), without significant correlation with overall survival, tumor size, or pleural invasion. Desmoplasia was significantly associated with higher PTB (<em>P</em> &lt; .001). Spread through airspaces was present in 34% and associated with lower PTB (<em>P</em> &lt; .001). To conclude, despite confirming TB as a reproducible factor in LUSC, we disclose areas of scoring ambiguity. Preoperative biopsy evaluation was insufficient in establishing the final TB score of the resected tumor.</p></div>\",\"PeriodicalId\":18706,\"journal\":{\"name\":\"Modern Pathology\",\"volume\":\"37 10\",\"pages\":\"Article 100571\"},\"PeriodicalIF\":7.1000,\"publicationDate\":\"2024-07-20\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.sciencedirect.com/science/article/pii/S0893395224001510/pdfft?md5=436d2a133269a6ef5b07a831d4ca6b68&pid=1-s2.0-S0893395224001510-main.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Modern Pathology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0893395224001510\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"PATHOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Modern Pathology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0893395224001510","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PATHOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

肺鳞状细胞癌(LUSC)的分级存在争议,并未被普遍接受。肿瘤出芽(TB)的组织形态学特征在结直肠癌中是一个公认的独立预后因素,在其他实体瘤中的重要性也与日俱增,使其成为肿瘤分级方案中的一个候选因素。我们的目的是比较肺鳞状细胞癌术前活检和切除标本中的 TB,并评估观察者之间的差异性。两位病理专家对伯尔尼(2000-2013 年,136 人)和洛桑(2005-2020 年,113 人)的 249 例连续肺鳞癌患者进行了回顾性队列分析,这些患者主要通过肺鳞癌切除术进行术前活检。分析结果与临床病理参数和存活率相关。在切除标本中,47.6%的病例瘤周芽生(PTB)评分较低(0-4个芽/0.785平方毫米),27.4%的病例评分中等(5-9个芽/0.785平方毫米),25%的病例评分较高(≥10个芽/0.785平方毫米)(中位数芽数=5,IQR=0-26)。在比较肿瘤边缘和肿瘤内区时,芽的绝对数量和 TB 评分相似(p=0.192),但与活组织检查的评分有显著差异(p=0.192)。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Multicenter Study on Tumor Budding in Lung Squamous Cell Carcinoma: Comparison Between Biopsy and Resection With Interobserver Variability Assessment

Grading lung squamous cell carcinoma (LUSC) is controversial and not universally accepted. The histomorphologic feature of tumor budding (TB) is an established independent prognostic factor in colorectal cancer, and its importance is growing in other solid cancers, making it a candidate for inclusion in tumor grading schemes. We aimed to compare TB between preoperative biopsies and resection specimens in pulmonary squamous cell carcinoma and assess interobserver variability. A retrospective cohort of 249 consecutive patients primarily resected with LUSC in Bern (2000-2013, n = 136) and Lausanne (2005-2020, n = 113) with available preoperative biopsies was analyzed for TB and additional histomorphologic parameters, such as spread through airspaces and desmoplasia, by 2 expert pathologists (M.M., C.N.). Results were correlated with clinicopathologic parameters and survival. In resection specimens, peritumoral budding (PTB) score was low (0-4 buds/0.785 mm2) in 47.6%, intermediate (5-9 buds/0.785 mm2) in 27.4%, and high (≥10 buds/0.785 mm2) in 25% of cases (median bud count, 5; IQR, 0-26). Both the absolute number of buds and TB score were similar when comparing tumor edge and intratumoral zone (P = .192) but significantly different from the score obtained in the biopsy (P < .001). Interobserver variability was moderate, regardless of score location (Cohen kappa, 0.59). The discrepant cases were reassessed, and consensus was reached in all cases with identification of causes of discordance. TB score was significantly associated with stage (P = .002), presence of lymph node (P = .033), and distant metastases (P = .020), without significant correlation with overall survival, tumor size, or pleural invasion. Desmoplasia was significantly associated with higher PTB (P < .001). Spread through airspaces was present in 34% and associated with lower PTB (P < .001). To conclude, despite confirming TB as a reproducible factor in LUSC, we disclose areas of scoring ambiguity. Preoperative biopsy evaluation was insufficient in establishing the final TB score of the resected tumor.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Modern Pathology
Modern Pathology 医学-病理学
CiteScore
14.30
自引率
2.70%
发文量
174
审稿时长
18 days
期刊介绍: Modern Pathology, an international journal under the ownership of The United States & Canadian Academy of Pathology (USCAP), serves as an authoritative platform for publishing top-tier clinical and translational research studies in pathology. Original manuscripts are the primary focus of Modern Pathology, complemented by impactful editorials, reviews, and practice guidelines covering all facets of precision diagnostics in human pathology. The journal's scope includes advancements in molecular diagnostics and genomic classifications of diseases, breakthroughs in immune-oncology, computational science, applied bioinformatics, and digital pathology.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信